Recent reports indicate the US economy experienced negative growth in the first quarter, creating a stark contrast with the stock market’s performance. This economic contraction comes at a time when ...

Analyst expectations are far above the prices you'd need to pay now to own a couple of biotechnology stocks. Compass Pathways is developing psilocybin as a treatment for depression. Viking ...

Investors seeking stocks that can put up dramatic gains in a short amount of time can find what they're looking for in the biotechnology industry. Investment bank analysts on Wall Street have tagged a ...